Sprouts Farmers Market Inc (NASDAQ: SFM) has reported E.P.S. of $0.80 for its fourth fiscal quarter (ending December 31) versus $0.49 for the same period a year ago — an increase of 63%. For the […]
For its fourth fiscal quarter (ending December 31), Shake Shack Inc (NYSE: SHAK) has reported a 22% increase in E.P.S. from $0.18 a year ago to $0.22 in the current quarter. For the latest four […]
Prothena Corp Plc (NASDAQ: PRTA) has reported E.P.S. of $-1.08 for its fourth fiscal quarter (ending December 31) versus $-1.26 for the same period a year ago — a decline of -14%. E.P.S. were $-2.27 […]
For its fourth fiscal quarter (ending December 31), Hasbro Inc. (NASDAQ: HAS) has reported a -97% decline in E.P.S. from $-7.64 a year ago to $-0.25 in the current quarter. E.P.S. were $2.77 for the […]
For its fourth fiscal quarter (ending December 31), Employers Holdings Inc (NYSE: EIG) has reported a -36% decline in E.P.S. from $1.78 a year ago to $1.14 in the current quarter. E.P.S. were $4.73 for […]
On 2/20/25, Crexendo Inc (NASDAQ: CXDO) stock enjoyed a major increase of 11.3%, closing at $6.98. Moreover, trading volume in this advance was exceptionally high at 510% of normal. The stock has risen 18.3% during […]
On 2/20/25, Corcept Therapeutics Inc (NASDAQ: CORT) stock suffered a major decline of -11.5%, closing at $65.09. Moreover, exceptionally high trading volume at 227% of normal accompanied the decline. Relative to the market the stock […]
Constellium SE (NYSE: CSTM) stock closed at $10.36 on 2/20/25 after a major increase of 14.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 285% of normal. The stock has been extremely […]
For its fourth fiscal quarter (ending December 31), Celsius Holdings Inc (NASDAQ: CELH) has reported a -159% decline in E.P.S. from $0.17 a year ago to $-0.10 in the current quarter. For the latest four […]
Aegon NV (NYSE: AEG) stock closed at $6.07 on 2/20/25 after a major decline of -10.1%. Moreover, trading volume in this decline was exceptionally high at 214% of normal. The stock has performed in line […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research